NCT02210806View on ClinicalTrials.gov

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
Asthma
Interventions
DRUG

A006 DPI

Single dose 110 mcg, 1 inhalation

DRUG

A006 DPI

Single dose 220 mcg, 1 inhalation

OTHER

Placebo DPI

Placebo, 1 inhalation

DRUG

Proventil® MDI

Single dose 90 mcg, 1 inhalation

DRUG

Proventil® MDI

Single dose 90 mcg, 2 inhalations

Trial Locations (4)

78130

Amphastar Site 0030, New Braunfels

78229

Amphastar Site 0032, San Antonio

95117

Amphastar Site 0001, San Jose

97504

Amphastar Site 0025, Medford

Sponsors
All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY